The clinical development of the glass‐ionomer cement. III. The erosion lesion*

Authors:
  • JMJ. W. McLean
    J. W. McLean
  • AWA. D. Wilson
    A. D. Wilson

Abstract
Abstract— A clinical trial of the glass‐ionomer cement, ASPA IV, as a restorative material for erosion lesions is reported. The failure rate, in a three‐year trial, was nine per cent; most failures occurring within the first few months after placement.